Clinical characteristics and beta cell function in Chinese patients with newly diagnosed type 2 diabetes mellitus with different levels of serum triglyceride.
BACKGROUND
To explore clinical characteristics and beta cell function in Chinese patients with newly diagnosed drug naive type 2 diabetes mellitus (T2DM) with different levels of serum triglyceride (TG).


METHODS
Patients with newly diagnosed T2DM (n = 624) were enrolled and divided into different groups according to levels of serum TG. All patients underwent oral glucose tolerance tests and insulin releasing tests. Demographic data, lipid profiles, glucose levels, and insulin profiles were compared between different groups. Basic insulin secretion function index (homeostasis model assessment for beta cell function index, HOMA-β), modified beta cell function index (MBCI), glucose disposition indices (DI), and early insulin secretion function index (insulinogenic index, IGI) were used to evaluate the beta cell function.


RESULTS
Patients of newly diagnosed T2DM with hypertriglyceridemia were younger, fatter and had worse lipid profiles, glucose profiles, and high insulin levels than those with normal TG. There is no difference in early phase insulin secretion among groups of newly diagnosed T2DM patients with different TG levels. The basal beta cell function (HOMA-β and MBCI) initially increased along rising TG levels and then decreased as the TG levels rose further. The insulin sensitivity was relatively high in patients with a low level of TG and low with a high level of TG.


CONCLUSIONS
Hypertriglyceridemia influences clinical characteristics and β cell function of Chinese patients with newly diagnosed T2DM. A better management of dyslipidemia may, to some extent, reduce the effect of lipotoxicity, thereby improving glucose homeostasis in patients with newly diagnosed T2DM.
Department of Endocrinology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, NO.160, Pujian Road, Shanghai, 200127, China. alicezhe_2005@qq.com.
Shuang
S
Zheng
Department of Endocrinology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, NO.160, Pujian Road, Shanghai, 200127, China. zhouhuan1969@163.com.
Huan
H
Zhou
Department of Endocrinology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, NO.160, Pujian Road, Shanghai, 200127, China. htt86226@163.com.
Tingting
T
Han
Department of Endocrinology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, NO.160, Pujian Road, Shanghai, 200127, China. 1756366571@qq.com.
Yangxue
Y
Li
Department of Endocrinology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, NO.160, Pujian Road, Shanghai, 200127, China. 475511243@qq.com.
Yao
Y
Zhang
Department of Endocrinology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, NO.160, Pujian Road, Shanghai, 200127, China. sue_liuwei@163.com.
Wei
W
Liu
Department of Endocrinology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, NO.160, Pujian Road, Shanghai, 200127, China. Amin1031@hotmail.com.
Yaomin
Y
Hu
D000328:Adult; D000368:Aged; D002681:China / Q000453:epidemiology; D003924:Diabetes Mellitus, Type 2 / Q000097:blood* / Q000453:epidemiology / Q000503:physiopathology*; D005260:Female; D006801:Humans; D015228:Hypertriglyceridemia / Q000097:blood / Q000453:epidemiology / Q000503:physiopathology; D007328:Insulin / Q000097:blood; D007333:Insulin Resistance; D050417:Insulin-Secreting Cells / Q000502:physiology*; D008055:Lipids / Q000097:blood; D008297:Male; D008875:Middle Aged; D014280:Triglycerides / Q000097:blood*
D007328:Insulin; D008055:Lipids; D014280:Triglycerides